|
Registry HBOT in DFU
RECRUITINGSponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Actively Recruiting
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Started2022-11-01
Est. completion2025-03
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06693180
Summary
Overview of available data to assess the benefits of HBOT to DFU patients
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Diabetes mellitus * Meggitt-Wagner classification grade 2-4, existing \> 4 weeks * Complete 1 year follow-up Exclusion Criteria: * Chronic Obstructive Pulmonary Disease (COPD) GOLD IV * Treatment with chemotherapy, immunosuppressive drugs or systemic corticosteroids within the last 3 months * Metastasized malignancy * Left ventricular ejection fraction (EF) \<20% or external pacemaker * Recent thoracic or middle ear surgery * Severe epilepsy * Uncontrollable high fever * Pregnancy
Conditions2
DiabetesDiabetic Foot Ulcers
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Started2022-11-01
Est. completion2025-03
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06693180